MediWound is a biotechnology company. It is focused on developing, manufacturing and globally commercializing products that address unmet needs in the fields of burn and chronic wound management. MediWound's aim is to provide healthcare professionals and patients with its burn wound eschar removal agent NexoBrid.
|Employees (est.) (Sep 2019)||73|
|Share Price (Oct 2019)||$3||(-1%)|
Market capitalization (15-Oct-2019)
Closing stock price (15-Oct-2019)
When was MediWound founded?
MediWound was founded in 2001.
How many employees does MediWound have?
MediWound has 73 employees.
Receive alerts for 300+ data fields across thousands of companies